Drug & Vaccine Development
The current COVID pandemic has ushered in a new era of rapid drug and vaccine development that is sure to result in a wave of litigation. WIT represents the most prominent life sciences and healthcare experts in the science, research & development, and clinical trial protocols involved in drug and vaccine development-related litigation.
WIT has been involved in some of the largest litigations associated with vaccines and drugs, including dozens of lawsuits associated with the opioid crisis, the pneumococcal vaccine, the mumps vaccine, and the influenza vaccine. Attorneys rely on WIT to provide a team of highly skilled experts who can assist them in cases involving intellectual property, antitrust, adverse effects, mass torts, mergers & acquisitions, and regulatory investigations.
WIT represents highly regarded academics, scientists, former regulators, and industry veterans who have years of consulting and testifying experience in the subjects most relevant to drug and vaccine litigation. Their knowledge includes areas such as immunology, vaccine efficacy, potency, regulatory affairs, drug development, and FDA compliance. Additionally, many of our experts are former pharmaceutical executives whose experience spans everything from product development to corporate transactions.
WIT’s experts have supported many of the most significant cases that challenge the pharmaceutical and life sciences industries.
WIT’s experts can assist in developing and advancing the strongest litigation posture in defense of major pharmaceutical and life sciences companies. Their expertise covers:
- Chemistry and Manufacturing Controls
- Clinical Trial Design
- Current Good Manufacturing Protocols
- FDA/CDC Compliance
- Good Clinical Practice
- Infectious Disease
- Research & Development
- Vector Development
- Viral/Bacterial Genetics